HK Stock Market Move | Partial photovoltaic stocks rise, XINTE ENERGY (01799) jumps over 5%. The Market Supervision Bureau issues guidance on price competition order compliance in the photovoltaic industry.
Some photovoltaic stocks rose, as of the time of writing, Xinyi SolartoNew Energy (00451) rose by 6.76% to 0.79 Hong Kong dollars; New Energy Jintai (01799) rose by 5.22% to 7.66 Hong Kong dollars; Xinxi Technology (03800) rose by 2.75% to 1.12 Hong Kong dollars; and Xinyi Solar Holdings (00968) rose by 1.32% to 3.06 Hong Kong dollars.
Some photovoltaic stocks rose, as of the time of publication, GCL NEWENERGY (00451) was up 6.76% at HK$0.79; XINTE ENERGY (01799) was up 5.22% at HK$7.66; GCL TECH (03800) was up 2.75% at HK$1.12; XINYI SOLAR (00968) was up 1.32% at HK$3.06.
On the news front, the State Administration for Market Regulation recently conducted a price competition order compliance guidance in the photovoltaic industry in Hefei, Anhui. The State Administration for Market Regulation will strictly crack down on illegal activities through increased supervision on product quality, strengthened price and anti-unfair competition law enforcement, effectively maintaining market fair competition order, and promoting the standardized and healthy sustainable development of the photovoltaic industry.
Huafu Securities believes that this move aims to crack down on illegal activities such as price collusion in the short term, and maintain a fair order; in the long term, it aims to guide the industry to shift from homogeneous low-price competition to a healthy development trajectory of technological innovation and high-quality pricing. This creates a more favorable environment for leading enterprises with technological and cost advantages, and resonates with the recent market behavior of silicon companies supporting price increases. The rules of industry competition are being reshaped, and high-quality development has become a clear direction.
Related Articles

ZGC TEC LEASING (01601) Signs Financing Lease Agreement

FUSEN PHARM(01652): "Compound Potassium Dihydrogen Phosphate Injection" approved for market.

Tech Inc. (06082) has attracted a strong demand for its IPO, with oversubscribed share offerings exceeding HKD 38 billion, oversubscribed by over 1500 times.
ZGC TEC LEASING (01601) Signs Financing Lease Agreement

FUSEN PHARM(01652): "Compound Potassium Dihydrogen Phosphate Injection" approved for market.

Tech Inc. (06082) has attracted a strong demand for its IPO, with oversubscribed share offerings exceeding HKD 38 billion, oversubscribed by over 1500 times.

RECOMMEND

Not Just “Power Shortages,” Delays Will Become The Key Theme For U.S. Data Centers In 2026
26/12/2025

Hang Seng Index Rises 33% This Year, Best Five‑Year Performance; Multiple Institutions Forecast Breakthrough Above 30,000 Next Year
26/12/2025

Gold Rally Has Further To Run, JPMorgan Bullish: Prices Could Reach USD 5,055 By Year‑End 2026
26/12/2025


